IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q1 2020 Holdings

Filed 2020-05-14 | 239 holdings | $801.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$2.7M8,5000.3%
Avantor Inc(AVTR)COM05352A100$3.9M314,5660.5%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$6.1M72,1000.8%
Beigene LTD(ONC)SPONSORED ADR07725L102$7.2M58,5000.9%
BIO RAD Labs Inc(BIO)CL A090572207$21.9M62,3732.7%
Caredx Inc(CDNA)COM14167L103$27.9M1,277,0513.5%
Black Diamond Therapeutics I(BDTX)COM09203E105$33.2M1,330,0004.1%
Align Technology Inc(ALGN)COM016255101$35.3M203,0764.4%
Charles RIV Labs Intl Inc(CRL)COM159864107$41.9M331,6235.2%
Centene Corp del(CNC)COM15135B101$48.1M810,2706.0%
Boston Scientific Corp(BSX)COM101137107$50.3M1,541,2256.3%
Arvinas Inc(ARVN)COM04335A105$51.2M1,269,3036.4%
Argenx SE(ARGX)SPONSORED ADR04016X101$128.4M974,50416.0%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$138.6M3,905,44417.3%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$193.2M1,775,26424.1%
PreviousPage 5 of 5